(Q41178359)

27 September 2017

title

The relationship of negative schizophrenia to parkinsonism (English)

1 reference

27 September 2017

1 reference

1 reference

Sandyk R

1

1 reference

27 September 2017

Kay SR

series ordinal

2

1 reference

27 September 2017

publication date

1 November 1990

1 reference

International Journal of Neuroscience

27 September 2017

published in

1 reference

27 September 2017

volume

55

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

1-59

1 reference

Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

HLA-B14 antigen and postencephalitic Parkinson's disease. Their association in an American-Jewish ethnic group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The Neuroleptic Hypothesis: Study of the Covariation of Extrapyramidal and Therapeutic Drug Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Positive vs. negative schizophrenia: a critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Partial improvement in negative schizophrenic symptoms after amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Effect of neuroleptics on positive and negative symptoms and the deficit state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

W.A.I.S. scores in a group of Parkinson patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cigarette smoking and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Asymmetrical cognitive deterioration in demented and Parkinson patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Regeneration of normal terminal innervation patterns by central noradrenergic neurons after 5,7-dihydroxytryptamine-induced axotomy in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Parkinsonism: Alterations in spatial orientation as determined by a route-walking test

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Central dopamine turnover in schizophrenic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration byl-Dopa1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Neuroleptic responsivity of negative and positive symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Sebum excretion in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Third ventricle enlargement and reduced electrodermal responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Treatment of negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Antiparkinsonian agents and depot phenothiazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Schizophrenia as dopamine-deficiency disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Positive and negative schizophrenic symptoms, attention, and information processing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The hypotheses of different dopamine receptor mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Molecular pathology of schizophrenia: more than one disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Is schizophrenia an infectious disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The two-syndrome concept: origins and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Gilles de la Tourette syndrome and the neurological basis of obsessions and compulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Comparative Doses and Costs of Antipsychotic Medication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Physostigmine: effects on cognition and affect in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The distribution of Lewy bodies in the central and autonomic nervous systems in idiopathic paralysis agitans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Performance on delayed response tasks by patients with Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Treatment of negative schizophrenia with d-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The Brain Stem in Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Zotepine in the treatment of negative symptoms in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Frontal lobe syndrome and depression in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

A strategy for developing novel drugs for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Pneumoencephalographic Findings in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cognition and symptomatology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Prevalence of Lewy bodies in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Akinesia, tardive dysmentia, and frontal lobe disorder in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The brain-stem lesions in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Orthostatic hypotension in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The effect of chlorpromazine upon psychophysiological, endocrine and information processing measures in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Two cases of accidental hypothermia in Parkinson's disease with unusual E.E.G. findings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

THE ORIGIN AND PURPOSES OF BLINKING

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Dopamine correlates of neurological and psychological status in untreated Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Some psychological factors in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

21 January 2018

ENCEPHALITIS LETHARGICA

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Relationship between primitive reflexes and severity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Is the mesocortical dopaminergic system involved in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Biochemistry of the hypothalamus in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Clinical signs in diffuse cerebral dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The dementia of dementia praecox

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The relative stability of positive and negative features in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Spontaneous eye-blink rates and dopaminergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Interactions between pineal, hypothalamus, and pituitary involving melatonin, MSH release-inhibiting factor and MSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Noradrenergic and neuroradiological abnormalities in tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Significance of positive and negative syndromes in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The projections of the A8, A9 and A10 dopaminergic cell bodies: evidence for a nigral-hypothalamic-median eminence dopaminergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The pharmacology of tardive dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

A standardized psychiatric assessment scale for rating chronic psychotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The hypothalamus in parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The diencephalon in schizophrenia: evidence for reduced thickness of the periventricular grey matter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: correlations to symptomatology and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Mesencephalic dopamine neurons projecting to neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Lateral ventricular size and drug-induced Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Increased brain dopamine and dopamine receptors in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Biological studies in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Perceptual capacity, functions of the corpus striatum and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Psychiatric symptoms in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The activities of noradrenergic and dopaminergic neuron systems in experimental hydrocephalus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Effects of levodopa on "frontal" signs in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Relationship of motor symptoms to intellectual deficits in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Developmental reflexes and cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Clinical correlates of sulcal widening in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Geographical considerations in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Primitive reflex activity in primary and symptomatic Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Dementia in Parkinson disease: a neuropsychological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Negative and positive symptoms in schizophrenia and depression: a followup

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Negative symptoms in schizophrenia: their longitudinal course and prognostic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

JUDGMENT OF VISUAL AND POSTURAL VERTICAL BY PARKINSONIAN PATIENTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Increased ventricle-to-brain ratio in late-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Changes in primate social behavior after treatment with alpha-methyl-para-tyrosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Pro-opiomelanocortin (POMC) processing in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Pineal melatonin functions: possible relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Serotonin in involuntary movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The hypothalamus in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Blood Sugar Levels in Patients Treated with Chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cerebral atrophy in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Drug-induced extrapyramidal symptoms: their incidence and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Melanocyte-stimulating hormone and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

A rating scale for tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Organic mental syndrome and confusional states in Parkinson's disease. Relationship to computerized tomographic signs of cerebral atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Features of brain atrophy in Parkinson's disease. A CT scan study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Drug-induced parkinsonism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Neuropathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The ventricular-brain ratio using planimetric measurement of EMI scans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The effect of deprenyl (selegiline) on the natural history of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Phenothiazines and Diabetes in Hospitalized Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Significance of cortical disinhibition signs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Possible virus in schizophrenia and some neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Is interruption of the nigro-striatal dopamine system producing the "lateral hypothalamus syndrome"?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

The human locus coeruleus in neurology and psychiatry. (Parkinson's, Lewy body, Hallervorden-Spatz, Alzheimer's and Korsakoff's disease, (pre)senile dementia, schizophrenia, affective disorders, psychosis).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

'Akinetic Depression' in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Computed tomography (CT) findings in schizophrenia: Speculation on the meaning of it all

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Increased concentration of alpha- and gamma-endorphin in post mortem hypothalamic tissue of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Psychiatric aspects of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Dopamine-β-Hydroxylase Deficits in the Brains of Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Positive and negative schizophrenic symptoms and the role of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Ventricular enlargement in schizophrenia: definition and prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

Melatonin, the pineal gland and human puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459008987178

10.3109/00207459008987178

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference